CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 59 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $136 | -69.7% | 198,492 | -46.9% | 0.01% | -73.3% |
| Q2 2023 | $449 | -15.1% | 374,100 | -17.3% | 0.04% | -13.5% |
| Q1 2023 | $529 | +34.3% | 452,561 | -9.3% | 0.05% | +6.1% |
| Q4 2022 | $394 | -99.8% | 498,783 | +252.7% | 0.05% | +113.0% |
| Q3 2022 | $171,000 | +10.3% | 141,408 | +216.7% | 0.02% | +35.3% |
| Q2 2021 | $155,000 | +52.0% | 44,655 | -22.3% | 0.02% | 0.0% |
| Q1 2021 | $102,000 | +191.4% | 57,465 | +69.9% | 0.02% | +183.3% |
| Q4 2020 | $35,000 | – | 33,832 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 196,867 | $181,000 | 0.05% |
| Wealth Advisory Solutions, LLC | 156,850 | $144,000 | 0.04% |
| Horst & Graben Wealth Management LLC | 75,722 | $70,000 | 0.02% |
| Ergoteles LLC | 451,890 | $416,000 | 0.01% |
| Miller Investment Management, LP | 50,000 | $46,000 | 0.01% |
| Virtu Financial LLC | 81,410 | $75,000 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 17,342 | $16,000 | 0.00% |
| Kestra Advisory Services, LLC | 71,102 | $65,000 | 0.00% |
| Csenge Advisory Group | 15,000 | $14,000 | 0.00% |
| Qube Research & Technologies Ltd | 121,281 | $112,000 | 0.00% |